As the rate of chronic diseases has increased, so has interest in treating mental health issues, Brenda Reiss-Brennan, PhD, mental health integration director at Intermountain Healthcare, said at the US News Hospital of Tomorrow conference.
As the rate of chronic diseases has increased, so has interest in treating mental health issues, Brenda Reiss-Brennan, PhD, mental health integration director at Intermountain Healthcare, said at the US News Hospital of Tomorrow conference.
One of the most common comorbidities is depression, and it isn’t possible to manage chronic diseases without addressing a barrier like mental health issues.
“So as we’ve gotten better at communicating with patients and families as what’s getting in the way of you managing your diabetes or managing your health and wellness, it’s become more evident that these social and mental health issues have to be addressed,” she said.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More